ArticleCell death & disease2024

IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer.

Hengxiao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.